WHO ICTRP trial

A clinical trial on SARAKKONDRAI ILAI CHOORANAM in the management of MADHUMEGA…

CTRI/2022/02/040177 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/02/040177
Public title A clinical trial on SARAKKONDRAI ILAI CHOORANAM in the management of MADHUMEGA AVATHAIGAL I-V (DIABETES MELLITUS AND ITS COMPLICATIONS)
Scientific title A prospective open labelled,non randomized, phase II clinical trial of SARAKKONDRAI ILAI CHOORANAM in the management of MADHUMEGA AVATHAIGAL I-V (DIABETES MELLITUS AND ITS COMPLICATIONS)
Primary sponsor Government Siddha Medical College and Hospital
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India
Conditions Health Condition 1: - Health Condition 2: - Health Condition 3: E00-E89- Endocrine, nutritional and metabolic diseases
Interventions Intervention1: SARAKKONDRAI ILAI CHOORANAM: 1250_1500mg/Twice a day (orally) with hot water Intervention2: SARAKKONDRAI ILAI CHOORANAM: 1250-1500mg/Twice a day with hot water for 90 days Control Intervention1: NIL: NIL
Registration date Oct 2, 2022
Target size 40
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations